| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.41B | 60.57B | 77.47B | 80.02B | 46.59B | 57.38B |
| Gross Profit | 22.15B | 20.76B | 35.14B | 44.31B | 15.55B | 9.10B |
| EBITDA | 11.34B | 10.16B | 27.53B | 38.34B | 10.03B | 4.58B |
| Net Income | 10.14B | 8.65B | 15.12B | 22.98B | 5.40B | -3.04B |
Balance Sheet | ||||||
| Total Assets | 118.61B | 117.63B | 99.74B | 95.03B | 67.84B | 70.62B |
| Cash, Cash Equivalents and Short-Term Investments | 10.60B | 8.97B | 34.34B | 39.47B | 21.56B | 23.85B |
| Total Debt | 31.80B | 33.21B | 8.67B | 13.55B | 12.88B | 23.77B |
| Total Liabilities | 51.37B | 52.14B | 35.71B | 38.42B | 32.30B | 40.33B |
| Stockholders Equity | 67.08B | 65.34B | 63.45B | 55.78B | 35.44B | 30.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.20B | 19.88B | 25.50B | 7.51B | 5.72B |
| Operating Cash Flow | 0.00 | 4.57B | 21.29B | 26.20B | 8.91B | 6.81B |
| Investing Cash Flow | 0.00 | -11.92B | -11.69B | -1.34B | 2.57B | -2.57B |
| Financing Cash Flow | 0.00 | -10.21B | -22.75B | -6.48B | -11.75B | 4.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥131.77B | 17.49 | ― | 2.57% | 7.46% | 153.98% | |
73 Outperform | ¥737.52B | 15.20 | ― | 3.93% | 2.57% | -4.79% | |
67 Neutral | ¥54.69B | 6.65 | ― | 2.80% | -5.73% | 102.36% | |
67 Neutral | ¥76.34B | 32.15 | ― | 1.37% | -5.02% | 186.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | ¥224.86B | 12.70 | ― | 3.45% | -4.87% | 26.27% | |
54 Neutral | ¥53.39B | 86.16 | ― | 5.78% | -30.85% | -38.79% |